Acute myocardial infarction and infarct size: do circadian variations play a role?

References

• Wu E, Ortiz JT, Tejedor P, et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart. 2008;94(6):730–736.
   PubMed Web of Science ®Google Scholar
• Pitcher A, Ashby D, Elliott P, Petersen SE. Cardiovascular MRI in clinical trials: expanded applications through novel surrogate endpoints. Heart. 2011;97(16):1286–1292
   Web of Science ®Google Scholar
• Cohen MC, Rohtla KM, Lavery CE, Muller JE, Mittleman MA. Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am JCardiol. 1997;79(11):1512–1516.
   PubMed Web of Science ®Google Scholar
• Durgan DJ, Pulinilkunnil T, Villegas-Montoya C, et al. Short communication: ischemia/reperfusion tolerance is time-of-day- dependent: mediation by the cardiomyocyte circadian clock. Circ Res. 2010;106(3):546–550.
   Web of Science ®Google Scholar
• Suarez-Barrientos A, Lopez-Romero P, Vivas D, et al. Circadian variations of infarct size in acute myocardial infarction. Heart. 2011;97(12):970–976.
   PubMed Web of Science ®Google Scholar
• Kwon I, Choe HK, Son GH, Kim K. Mammalian Molecular Clocks. Exp Neurobiol 2011;20(1):18–28.
   PubMedGoogle Scholar
• Saini C, Suter DM, Liani A, Gos P Schibler U. The mammalian circadian timing system: synchronization of peripheral clocks. Cold Spring Harb Symp Quant Biol. December 16 2011; [Epub ahead of print.]
   Google Scholar
• Albrecht U. Circadian clocks in mood-related behaviors. Ann Med. 2010;42(4):241–251.
   PubMed Web of Science ®Google Scholar
• Degaute JP, Van Cauter E, van de Borne P, Linkowski P. Twenty-four- hour blood pressure and heart rate profiles in humans. A twin study. Hypertension. 1994;23(2):244–253.
   Web of Science ®Google Scholar
• Linsell CR, Lightman SL, Mullen PE, Brown MJ, Causon RC. Circadian rhythms of epinephrine and norepinephrine in man. J Clin Endocrinol Metab. 1985;60(6):1210–1215.
   PubMed Web of Science ®Google Scholar
• Turton MB, Deegan T. Circadian variations of plasma catecholamine, cortisol and immunoreactive insulin concentrations in supine subjects. Clin Chim Acta. 1974;55(3):389–397.
   Web of Science ®Google Scholar
• Hurwitz S, Cohen RJ, Williams GH. Diurnal variation of aldosterone and plasma renin activity: timing relation to melatonin and cortisol and consistency after prolonged bed rest. J Appl Physiol. 2004;96(4):1406–1414.
   Web of Science ®Google Scholar
• Armbruster H, Vetter W, Beckerhoff R, Nussberger J, Vetter H, Seigenthaler W. Diurnal variations of plasma aldosterone in supine man: relationship to plasma renin activity and plasma cortisol. Acta Endocrinol (Copenh). 1975;80(1):95–103.
   Google Scholar
• Pevet P, Challet E. Melatonin: both master clock output and internal time-giver in the circadian clocks network. J Physiol Paris. 2011;105(4–6):170–182.
   PubMedGoogle Scholar
• Reiter RJ, Tan DX. Melatonin and cardiac pathophysiology. Heart Metab. 2009;44:31–34.
   Google Scholar
• Richards AM, Nicholls MG, Espiner EA, Ikram H, Cullens M, Hinton D. Diurnal patterns of blood pressure, heart rate and vasoactive hormones in normal man. Clin Exp Hypertens A. 1986;8(2):153–166.
   PubMed Web of Science ®Google Scholar
• Rudic RD, Fulton DJ. Pressed for time: the circadian clock and hypertension. J Appl Physiol. 2009;107(4):1328–1338.
   Web of Science ®Google Scholar
• Tofler GH, Brezinski D, Schafer AI, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med. 1987;316(24):1514–1518.
   PubMed Web of Science ®Google Scholar
• Petralito A, Mangiafico RA, Gibiino S, Cuffari MA, Miano MF, Fiore CE. Daily modification of plasma fibrinogen platelets aggregation, Howell’s time, PTT, TT, and antithrombin III in normal subjects and in patients with vascular disease. Chronobiologia. 1982;9(2):195–201.
   Google Scholar
• Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation. 1989;79(1):101–106.
   PubMed Web of Science ®Google Scholar
• Davidson AJ, London B, Block GD, Menaker M. Cardiovascular tissues contain independent circadian clocks. Clin Exp Hypertens. 2005;27(2–3):307–311.
   PubMed Web of Science ®Google Scholar
• Durgan DJ, Hotze MA, Tomlin TM, et al. The intrinsic circadian clock within the cardiomyocyte. Am J Physiol Heart Circ Physiol. 2005;289(4):H1530–H1541.
   Web of Science ®Google Scholar
• Durgan DJ, Young ME. The cardiomyocyte circadian clock: emerging roles in health and disease. Circ Res. 2010;106(4):647–658.
   Web of Science ®Google Scholar
• Martinez-Nicolas A, Ortiz-Tudela E, Madrid JA, Rol MA. Crosstalk between environmental light and internal time in humans. Chronobiol Int. 2011;28(7):617–629.
   PubMed Web of Science ®Google Scholar
• Lowrey PL, Takahashi JS. Genetics of circadian rhythms in mammalian model organisms. Adv Genet. 2011;74:175–230.
   PubMed Web of Science ®Google Scholar
• Damiola F, Le Minh N, Preitner N, Kornmann B, Fleury-Olela F, Schibler U. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev. 2000;14(23):2950–2961.
   PubMed Web of Science ®Google Scholar
• Westgate EJ, Cheng Y, Reilly DF, et al. Genetic components of the circadian clock regulate thrombogenesis in vivo. Circulation. 2008;117(16):2087–2095.
   PubMed Web of Science ®Google Scholar
• Anea CB, Zhang M, Stepp DW, et al. Vascular disease in mice with a dysfunctional circadian clock. Circulation. 2009;119(11):1510–1517.
   Web of Science ®Google Scholar
• Viswambharan H, Carvas JM, Antic V et al. Mutation of the circadian clock gene Per2 alters vascular endothelial function. Circulation. 2007;115(16):2188–2195.
   PubMed Web of Science ®Google Scholar
• Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989;79(4):733–743.
   PubMed Web of Science ®Google Scholar
• Mehta RH, Manfredini R, Hassan F, et al. Chronobiological patterns of acute aortic dissection. Circulation. 2002;106(9):1110–1115.
   PubMed Web of Science ®Google Scholar
• Arntz HR, Willich SN, Schreiber C, Brüggemann T, Stern R, Schultheiss HP. Diurnal, weekly and seasonal variation of sudden death. Population-based analysis of 24,061 consecutive cases. Eur Heart J. 2000;21(4):315–320.
   PubMed Web of Science ®Google Scholar
• Morning peak in the incidence of myocardial infarction: experience in the ISIS-2 trial. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Eur Heart J. 1992;13(5):594–598.
   Google Scholar
• Englund A, Behrens S, Wegscheider K, Rowland E. Circadian variation of malignant ventricular arrhythmias in patients with ischemic and nonischemic heart disease after cardioverter defibrillator implantation. European 7219 Jewel Investigators. J Am Coll Cardiol. 1999;34(5):1560–1568.
   PubMed Web of Science ®Google Scholar
• Manfredini R, Boari B, Gallerani M, et al. Chronobiology of rupture and dissection of aortic aneurysms. J Vasc Surg. 2004;40(2):382–388.
   Web of Science ®Google Scholar
• Elliott WJ. Circadian variation in the timing of stroke onset: a meta-analysis. Stroke. 1998;29(5):992–996.
   PubMed Web of Science ®Google Scholar
• Gnecchi-Ruscone T, Piccaluga E, Guzzetti S, Contini M, Montano N, Nicolis E. Morning and Monday: critical periods for the onset of acute myocardial infarction. The GISSI 2 Study experience. Eur Heart J. 1994;15(7):882–887.
   PubMed Web of Science ®Google Scholar
• Takeda N, Maemura K. Circadian clock and cardiovascular disease. J Cardiol 2011;57(3):249–256.
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res. 2004;61(3):448–460.
   PubMed Web of Science ®Google Scholar
• Iitaka C, Miyazaki K, Akaike T, Ishida N. A role for glycogen synthase kinase-3beta in the mammalian circadian clock. J Biol Chem. 2005;280(33):29397–29402.
   Web of Science ®Google Scholar
• Miura T, Miki T. GSK-3beta, a therapeutic target for cardiomyocyte protection. Circ J. 2009;73(7):1184–1192.
   Web of Science ®Google Scholar
• Reiter R, Swingen C, Moore L, Henry TD, Traverse JH. Circadian dependence of infarct size and left ventricular function after ST elevation myocardial infarction. Circ Res. 2011;110(1):105–110.
   Web of Science ®Google Scholar
• Arroyo Úcar E, Dominguez-Rodriguez A, Abreu-Gonzalez P. Influencia de la variabilidad diurna en el tamaño del infarto agudo de miocardio [Influence of diurnal variation in the size of acute myocardial infarction]. Med Intensiva. 2012;36(1):11–14. Spanish.
   Web of Science ®Google Scholar
• De Luca G, Suryapranata H, Ottervanger JP, et al. Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Am Heart J. 2005;150:1185–1189.
   PubMedGoogle Scholar
• Magid DJ, Calonge BN, Rumsfeld JS, et al. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. JAMA. 2000;284:3131–3138.
   PubMed Web of Science ®Google Scholar
• Henriques JP, Haasdijk AP, Zijlstra F, Zwolle Myocardial Infarction Study Group. Outcome of primary angioplasty for acute myocardial infarction during routine duty hours versus during off-hours. J Am Coll Cardiol. 2003;41(12):2138–2142.
   Web of Science ®Google Scholar
• Dominguez-Rodriguez A, Garcia-Gonzalez M, Abreu-Gonzalez P Outcome of primary angioplasty for ST-segment elevation myocardial infarction during routine duty hours versus during off-hours. Results of a single-center in Spain. Int J Cardiol. 2007;119(2):227–229.
   Web of Science ®Google Scholar
• Kurnik PB. Circadian variation in the efficacy of tissue-type plasminogen activator. Circulation. 1995;91(5):1341–1346.
   PubMed Web of Science ®Google Scholar
• Goldhammer E, Kharash L, Abinader EG. Circadian fluctuations in the efficacy of thrombolysis with streptokinase. Postgrad Med J. 1999;75(889):667–671.
   Web of Science ®Google Scholar
• Garot P, Juliard JM, Benamer H, Steg PG. Are the results of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction different during the “off” hours? Am J Cardiol. 1997;79(11):1527–1529.
   Web of Science ®Google Scholar
• Zahn R, Schiele R, Seidl K, et al. Daytime and nighttime differences in patterns of performance of primary angioplasty in the treatment of patients with acute myocardial infarction. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Am Heart J. 1999;138(6 Pt 1):1111–1117.
   Web of Science ®Google Scholar
• Mingo S, Goicolea J, Nombela L, et al. Angioplastia primaria en nuestro medio. Análisis de los retrasos hasta la reperfusión, sus condicionantes y su implicación pronóstica [Primary percutaneous angioplasty. An analysis of reperfusion delays, their determining factors and their prognostic implications]. RevEsp Cardiol. 2009;62(1):15–22. Spanish.
   Google Scholar
• Grimaudo V Hauert J, Bachmann F, Kruithof EK. Diurnal variation of the fibrinolytic system. Thromb Haemost. 1988;59(3):495–499.
   Web of Science ®Google Scholar
• Andreotti F, Davies GJ, Hackett DR, et al. Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am J Cardiol. 1988;62(9):635–637.
   Web of Science ®Google Scholar
• Kelle S, Roes SD, Klein C, et al. Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging. J Am Coll Cardiol. 2009;54(19):1770–1777.
   PubMed Web of Science ®Google Scholar
• Watzinger N, Lund GK, Higgins CB, Wendland MF, Weinmann HJ, Saeed M. The potential of contrast-enhanced magnetic resonance imaging for predicting left ventricular remodeling. J Magn Reson Imaging. 2002;16(6):633–640.
   Web of Science ®Google Scholar
• Yee KM, Pringle SD, Struthers AD. Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure. J Am Coll Cardiol. 2001;37(7):1800–1807.
   PubMed Web of Science ®Google Scholar
• Willich SN, Linderer T, Wegscheider K, Leizorovicz A, Alamercery I, Schroder R. Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group. Circulation. 1989;80(4):853–858.
   PubMed Web of Science ®Google Scholar
• Peters RW, Muller JE, Goldstein S, Byington R, Friedman LM. Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT Study). Am J Cardiol 1989;63(20):1518–1520.
   Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 2010;27(8):1629–1651.
   PubMed Web of Science ®Google Scholar
• Macchiarulo C, Pieri R, Mitolo DC, Pirrelli A. Management of antihypertensive treatment with Lisinopril: a chronotherapeutic approach. Eur Rev Med Pharmacol Sci. 1999;3(6):269–275.
   PubMedGoogle Scholar
• Palatini P, Racioppa A, Raule G, Zaninotto M, Penzo M, Pessina AC. Effect of timing of administration on the plasma ACE inhibitor activity and the antihypertensive effect of quinapril. Clin Pharmacol Ther. 1992;52(4):378–383.
   Web of Science ®Google Scholar
• Sundberg S, Luurila OJ, Kohvakka A, Gordin A. The circadian heart rate but not blood pressure profile is influenced by the timing of 6-blocker administration in hypertensives. Eur J Clin Pharmacol 1991;40(4):435–436.
   Web of Science ®Google Scholar
• Mengden T, Binswanger B, Spühler T, Weisser B, Vetter W. The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening. J Hypertens. 1993;11(12):1403–1411.
   Web of Science ®Google Scholar
• Lemmer B. Differential effects of antihypertensive drugs on circadian rhythm in blood pressure from the chronobiological point of view. Blood Press Monit. 1996;1:161–169.
   PubMedGoogle Scholar
• Voogel AJ, van der Meulen JH, van Montfrans GA. Effects of antihypertensive drugs on the circadian blood pressure profile. J Cardiovasc Pharmacol. 1996;28(3):463–469.
   Web of Science ®Google Scholar
• Pickering TG, Levenstein M, Walmsley P. Nighttime dosing of doxazosin has peak effect on morning ambulatory blood pressure. Results of the HALT Study. Hypertension and Lipid Trial Study Group. Am J Hypertens. 1994;7(9 Pt 1):844–847.
   PubMed Web of Science ®Google Scholar
• White WB, Anders RJ, MacIntyre JM, Black HR, Sica DA. Nocturnal dosing of a novel delivery system of verapamil for systemic hypertension. Verapamil Study Group. Am J Cardiol. 1995;76(5):375–380.
   PubMed Web of Science ®Google Scholar